Serial Number
97515418
Owner
Protean BioDiagnostics Inc.Attorney
Allison R. ImberFirst Use Date
Oct 9, 2017
Filing Date
Jul 22, 2022
PROTEAN BIODIAGNOSTICS Trademark
Serial Number: 97515418 • Registration: 7757272
Trademark Classes
Owner Contact Info
7573 Laureate Blvd., Unit 1307
Orlando, FL 32827
Entity Type: 03
Legal Representation
Correspondence Address
Allison R. Imber ALLEN, DYER, DOPPELT & GILCHRIST, P.A.
255 S. ORANGE AVENUE, SUITE 1401
ORLANDO, FL 32801
United States
Trademark Details
Filing Date
July 22, 2022
Registration Date
April 15, 2025
First Use Anywhere
October 9, 2017
First Use in Commerce
March 8, 2018
Published for Opposition
February 25, 2025
Goods & Services
Genetic testing for medical purposes; DNA screening for medical purposes; Medical diagnostic testing, monitoring and reporting services; Medical services; Medical analysis services for the diagnosis and treatment of cancer; Medical services, namely, pathology services for the diagnosis and treatment of disease; none of the foregoing services including monitoring the variables or changes in genomes, DNA, or genes
Medical laboratory services; Medical research services; Scientific laboratory services; Biomedical research services; Chemical research services; Pharmaceutical research services; Genetic testing for scientific research purposes; DNA analysis services for scientific research purposes; Medical and scientific research in the field of immunohistochemistry, in-situ hybridization, molecular diagnostics, genetics, and pathology; Medical and scientific research services, namely, identifying genetic characteristics that affect patients' likelihood or inherited risk of developing cancer and their responsiveness or resistance to cancer treatments and therapies, and the reasons for such likelihood, inherited risk or resistance; Medical and scientific research services, namely, identifying genetic characteristics to predict the prognosis, clinical course, and likelihood of recurrence of patients' cancers, illnesses or malignancies and the effectiveness of treatments and therapies therefor; none of the foregoing services including monitoring the variables or changes in genomes, DNA, or genes
